Trademark: 85390392
Word
CHANTILLY BIOPHARMA
Status
Dead
Status Code
602
Status Date
Thursday, July 5, 2012
Serial Number
85390392
Mark Type
4000
Filing Date
Friday, August 5, 2011
Abandoned Date
Monday, June 11, 2012

Trademark Owner History

Classifications
5 Analgesic and muscle relaxant pharmaceutical preparations; Anti-diabetic pharmaceuticals; Antibacterial pharmaceuticals; Antimicrobial preparations for inhibiting microbiological decomposition in food, beverages, animal feed and pharmaceuticals; Antimicrobial preservatives for cosmetics and pharmaceuticals; Astringents; Balms for pharmaceutical purposes; Cardiovascular pharmaceuticals; Cellulose esters for pharmaceutical purposes; Cellulose ethers for pharmaceutical purposes; Charcoal for pharmaceutical purposes; Chemical preparations for pharmaceutical or medical purposes, namely, for active pharmaceuticals; Dermatological pharmaceutical products; Digestives for pharmaceutical purposes; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of a coating for pharmaceutical actives that facilitate the delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Ferments for pharmaceutical purposes; Gelatin capsules sold empty for pharmaceuticals; Homeopathic pharmaceuticals for use in the treatment of colds and the flu; Hyaluronic acid for pharmaceutical purposes; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Inhalers filled with pharmaceutical actives; Injectable pharmaceuticals for treatment of anaphylactic reactions; Intravenous fluids used for rehydration, nutrition and the delivery of pharmaceutical preparations; Ocular pharmaceuticals; Pharmaceutical anti-allergic preparations and substances; Pharmaceutical antitussive-cold preparations; Pharmaceutical for the treatment of erectile dysfunction; Pharmaceutical preparation for skin care; Pharmaceutical preparation for the treatment of gout; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of psychiatric diseases and disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for animal skincare; Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension
"BIOPHARAMA"
CHANTILLY BIO PHARMA

Trademark Events
Jul 5, 2012
Abandonment Notice Mailed - Failure To Respond
Jul 5, 2012
Abandonment - Failure To Respond Or Late Response
Dec 8, 2011
Combined Examiner's Amendment/Priority Action Entered
Dec 8, 2011
Assigned To Lie
Dec 8, 2011
Notification Of Examiner's Amendment/Priority Action E-Mailed
Dec 8, 2011
Examiner's Amendment/Priority Action E-Mailed
Dec 8, 2011
Examiners Amendment And/Or Priority Action - Completed
Nov 30, 2011
Assigned To Examiner
Aug 10, 2011
Notice Of Pseudo Mark Mailed
Aug 9, 2011
New Application Office Supplied Data Entered In Tram
Aug 9, 2011
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24